Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in three Southeast Asian women with kidney failure may be linked to their anemia treatment with erythropoietin.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

A man developed a rare skin condition and drug-induced lupus, highlighting the need for biopsy in diagnosing skin issues caused by sunlight.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Daylight photodynamic therapy is effective and well-tolerated for treating actinic keratoses with minimal side effects.

Combining topical dutasteride with microneedling is more effective for hair growth than microneedling alone.

Hair loss may indicate higher risk of heart disease.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Baricitinib is effective and safe for treating severe alopecia areata.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

HPV vaccines are generally safe but need further investigation for rare side effects.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.